Condition

Congestive Heart Failure (CHF)

ClinicalTrials.gov condition label

Clinical trials16

Recruiting2

Common interventions16

Lead sponsors shown15

Clinical trials

16 shown

The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular CongestionNCT07705269 · 2026-06-04

Palliative Care for People With HFNCT07356843 · 2025-10-29

Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient DepartmentNCT06683053 · 2023-03-17

ACTIVE_NOT_RECRUITING

Developing Enhanced Prediction ModelsNCT02983812 · 2017-01-23

Clinical Trials for Elderly Patients With Multiple DiseaseNCT01960907 · 2013-10-01

Expanding Paramedicine in the CommunityNCT02034045 · 2013-06-01

Pulmonary Blood Flow Measurements in CHF PatientsNCT01831713 · 2012-09-01

Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart FailureNCT01744210 · 2012-09-01

Group Psychotherapy Among Congestive Heart Failure PatientsNCT01414439 · 2011-08-01

Outlook Quality of Life Intervention StudyNCT01044290 · 2011-01-01

A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice ResponseNCT01855022 · 2010-06-01

Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma SamplesNCT00734045 · 2008-02-01

Recombinant Human Relaxin for the Treatment of Decompensated CHFNCT00406575 · 2006-11-01

CHF Management Using TelemedicineNCT00309764 · 2001-11-01

Improving Heart Failure Care in Minority CommunitiesNCT00211874 · 2000-09-01

Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) SystemNCT00528320

APPROVED_FOR_MARKETING

Common interventions

ADAPTOTHER1 Attention ControlOTHER1 CHROMED monitoring systemDEVICE1 Community ParamedicineOTHER1 empagliflozinDRUG1 Existential Group TherapyBEHAVIORAL1 High-rate ultrafiltrationPROCEDURE1 Life CompletionOTHER1 MI + IVRBEHAVIORAL1 Nurse-managementBEHAVIORAL1 Ovatio CRTDEVICE1 PlaceboDRUG1 Recombinant human relaxin (rhRlx)DRUG1 Standard fluid removalPROCEDURE1 TelemedicineBEHAVIORAL1 Usual CareOTHER1

Leading sponsors

Echosense Ltd.2 Asante Health System1 Conrado Roberto Hoffmann Filho1 Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies1 ELA Medical, Inc.1 Icahn School of Medicine at Mount Sinai1 Indiana University1 Kaiser Permanente1 Meir Medical Center1 Nanogen, Inc.1 Restech Srl1 Unity Health Toronto1 Universidad Autonoma de Nuevo Leon1 University of Pennsylvania1 VA Office of Research and Development1

Trial status mix

COMPLETED8

RECRUITING2

TERMINATED2

ACTIVE_NOT_RECRUITING1

APPROVED_FOR_MARKETING1

UNKNOWN1

WITHDRAWN1

Phase mix

NA7

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.